Pragmetis Pharmaserve Llp Profile
Key Indicators
- Obligation of Contribution ₹ 0.10 M
as on 20-01-2024
- Company Age 11 Year, 8 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 Cr
as on 20-01-2024
- Revenue 13.22%
(FY 2021)
- Profit 36.69%
(FY 2021)
- Ebitda 22.45%
(FY 2021)
- Total Assets 2.01%
(FY 2021)
About Pragmetis Pharmaserve Llp
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 0.10 M as per MCA.
- CIN/LLPIN/FCRN
AAC-0087
- Incorporation Date
16 Jan 2014
- Date of Accounts and Solvency Statement
31 Mar 2023
- ROC Code
Roc-Ahmedabad
- Company Classification
Limited Liability Partnership
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Pragmetis Pharmaserve Llp offer?
Pragmetis Pharmaserve Llp offers a wide range of products and services, including Corporate and Soft Skills Training, Corporate Training, Chemical Reagents & Catalysts, Organic Compounds.
Who are the key members and board of directors at Pragmetis Pharmaserve Llp?
Designated Partners (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anurag Hitkari  | Designated Partner | 16-Jan-2014 | Current |
| Alpana Hitkari | Designated Partner | 16-Jan-2014 | Current |
Financial Performance of Pragmetis Pharmaserve Llp.
Pragmetis Pharmaserve Llp, for the financial year ended 2021, experienced significant growth in revenue, with a 13.22% increase. The company also saw a substantial improvement in profitability, with a 36.69% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pragmetis Pharmaserve Llp?
Unlock access to Pragmetis Pharmaserve Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
₹10.00 M
₹0
Charges Breakdown by Lending Institutions
- Small Industries Development Bank Of India (Sidbi) : 0.50 Cr
- Axis Bank Limited : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Apr 2023 | Axis Bank Limited | ₹5.00 M | Open |
| 07 May 2020 | Small Industries Development Bank Of India (Sidbi) | ₹5.00 M | Open |
How Many Employees Work at Pragmetis Pharmaserve Llp?
Unlock and access historical data on people associated with Pragmetis Pharmaserve Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pragmetis Pharmaserve Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pragmetis Pharmaserve Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.